← Evidence map

ArticleAntibody therapeutics2024

FcRider: a recombinant Fc nanoparticle with endogenous adjuvant activities for hybrid immunization.

Changchuin Mao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 39381134